Ability Biologics
Highly Engaged Employees
Highly Engaged EmployeesBlood & Organ Banks · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3 Place Ville Marie Ste 400, Montreal, Q...Website
ability.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
2
3
2
3
1
About Ability Biologics
Based in Montreal, Quebec, Ability Biologics is a biotherapeutics company and cell targeting solutions providerExplore more
Ability Biologics Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ability Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Ability Biologics had a recent Job posting/layoffs
Check if Ability Biologics has recently received funding, and reach out quickly before it becomes old news!
Check out if Ability Biologics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Ability Biologics
Product Launch: Get notified when Ability Biologics launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Ability Biologics recently announced quarterly report
Ability Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Ability Biologics has new funding data
Recommended Actions
Reach out to Masked Content who joined Ability Biologics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Ability Biologics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Ability Biologics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Ability Biologics.
Ability Biologics financials insights
Gather financial insights about Ability Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$18M
Ability Biologics Tech Stack
A closer look at the technologies used by Ability Biologics
Ability Biologics News & Media
Ability Biotherapeutics Moves to Inspire Bio Innovations in Montreal, Pioneering the New Generation of Targeted Antibodies
MONTREAL--(BUSINESS WIRE)-- #Antibodies--Ability Biotherapeutics, a Quebec-based leader in antibody therapeutics, is proud to announce its new location at Inspire Bio Innovations. The company will occupy the 6th floor of Phase 2 in the transformative redevelopment of the former Montreal Chest Institute, marking a significant step in its growth within Montreal’s thriving life sciences ecosystem. The project’s first phase is scheduled for completion this summer, with the second phase, including AbMila Partners with Ability Biologics to Advance AI Innovations in Antibody Discovery
MONTREAL--(BUSINESS WIRE)-- #AI--Ability Biologics (“Ability”) is proud to announce a new partnership with Mila - Quebec Artificial Intelligence Institute. This partnership will bring together Mila’s world-renowned network of experts and researchers in artificial intelligence (AI) and machine learning, with Ability’s deep experience in immunology, antibody discovery, engineering and therapeutic development, creating a transformative synergy from research to clinical and commercial stage. AbilityAbility Biologics Announces the Closing of its US $18 Million Seed Funding Extension toward the Generation of Novel, Highly Targeted Immunomodulators
MONTREAL, June 18, 2024 /PRNewswire/ - Ability Biologics ("Ability") announced the final closing of its seed funding, raising a total of $18 million (US), a financing round led by founding investor Amplitude Ventures ("Amplitude"). Amplitude is joined by the Fonds de solidarité FTQ,...Ability Biologics Announces the Closing of its US $18 Million Seed Funding Extension toward the Generation of Novel, Highly Targeted Immunomodulators
MONTREAL, June 18, 2024 /PRNewswire/ -- Ability Biologics ("Ability") announced the final closing of its seed funding, raising a total of $18 million (US), a financing round led by founding investor Amplitude Ventures ("Amplitude"). Amplitude is joined by the Fonds de solidarité FTQ,...
Read more news
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ability Biologics
Sign Up For FreeTo access detailed company insights
Based in Montreal, Quebec, Ability Biologics is a biotherapeutics company and cell targeting solutions provider... Read More
